OA06.03 SAFFRON-301: Tislelizumab Plus Sitravatinib in Advanced/Metastatic NSCLC Progressing on/after Chemotherapy and Anti-PD-(L)1

作者：Qunfang Zhou, Bo Gao, Jing Hu, Jun Zhao, M. Wang, Ke He, Wei Zhang, Chao Liu, Jing Fang, XingYa Li, Zhi Wang, María João Matos, Vineet Kwatra, XingYa Li, Yanjie Chen, Jiän Zhang, Jing Wang, Yinghao Wu · 发表于：Journal of Thoracic Oncology · 年份：2024 · DOI：10.1016/j.jtho.2024.09.041 · 被引用次数：5 · 研究领域：Advanced Breast Cancer Therapies、Cancer Immunotherapy and Biomarkers、Fibroblast Growth Factor Research